Dr. Zoe Cournia
Dr. Zoe Cournia is a Researcher – Associate Professor level at the Biomedical Research Foundation, Academy of Athens, where she works on anticancer drug and materials design using High Performance Computing and Artificial Intelligence (http://www.drugdesign.gr). She graduated from the Chemistry Department, University of Athens in 2001 and received her PhD at the University of Heidelberg in Germany in 2006. She then worked as a postdoctoral researcher at the Chemistry Department, Yale University, USA, on computer-aided drug design and in 2009 she became a Lecturer at Yale College. She has been awarded with the American Association for Cancer Research Angiogenesis Fellowship (2008), the “Woman of Innovation 2009” Award from the Connecticut Technology Council, USA, the Marie Curie Fellowship from the European Union (2010), the “Outstanding Junior Faculty Award” from the American Chemical Society (2014) and the first “Ada Lovelace Award” from the “Partnership for Advanced Computing in Europe” (2016). She was a member of the Infrastructure Advisory Group (INFRAG) of the European High Performance Computing Joint Undertaking in 2018-2021 and in 2022 she was appointed as the Greek representative in the Innovative Health Initiative Joint Undertaking. She is an Executive Editor with the Journal of Chemical information and Modeling, American Chemical Society and the national representative of Greece in the Division of Computational and Theoretical Chemistry in the European Chemical Society. She is currently teaching at the Master’s program “Data Science and Information Technologies” at the Department of Informatics and Telecommunications, National University of Athens.